Clinical Research

1119 results

Hookworm and anaemia prevalence.Guyatt HL, Brooker S, Peshu N, Shulman CE
Lancet, (2000). 356:2101

Arginine vasopressin secretion in Kenyan children with severe malaria.Sowunmi A, Newton CR, Waruiru C, Lightman S, Dunger DB
J Trop Pediatr, (2000). 46:195-9

Cerebral malaria.Newton CR, Hien TT, White N
J Neurol Neurosurg Psychiatry, (2000). 69:433-41

HTLV-1 and HIV infections of the central nervous system in tropical areas.Cabre P, Smadja D, Cabie A, Newton CR
J Neurol Neurosurg Psychiatry, (2000). 68:550-7

Neurological aspects of tropical disease.Farrar J, Newton C
J Neurol Neurosurg Psychiatry, (2000). 68:135-6

Fibrocalculous pancreatic diabetes in a child: case report.Osier FH, Newton CR
East Afr Med J, (1999). 76:703-5

Cognitive sequelae of severe malaria with impaired consciousness.Holding PA, Stevenson J, Peshu N, Marsh K
Trans R Soc Trop Med Hyg, (1999). 93:529-34

Bacteraemia complicating severe malaria in children.Berkley J, Mwarumba S, Bramham K, Lowe B, Marsh K
Trans R Soc Trop Med Hyg, (1999). 93:283-6

The epidemiology of hookworm infection and its contribution to anaemia among pre-school children on the Kenyan coast.Brooker S, Peshu N, Warn PA, Mosobo M, Guyatt HL, Marsh K, Snow RW
Trans R Soc Trop Med Hyg, (1999). 93:240-6

A polymorphism that affects OCT-1 binding to the TNF promoter region is associated with severe malaria.Knight JC, Udalova I, Hill AV, Greenwood BM, Peshu N, Marsh K, Kwiatkowski D
Nat Genet, (1999). 22:145-50

Cerebral malaria versus bacterial meningitis in children with impaired consciousness.Berkley JA, Mwangi I, Mellington F, Mwarumba S, Marsh K
QJM, (1999). 92:151-7

Intermittent sulphadoxine-pyrimethamine to prevent severe anaemia secondary to malaria in pregnancy: a randomised placebo-controlled trial.Shulman CE, Dorman EK, Cutts F, Kawuondo K, Bulmer JN, Peshu N, Marsh K
Lancet, (1999). 353:632-6

Environmental and entomological risk factors for the development of clinical malaria among children on the Kenyan coast.Snow RW, Peshu N, Forster D, Bomu G, Mitsanze E, Ngumbao E, Chisengwa R, Schellenberg JR, Hayes RJ, Newbold CI, Marsh K
Trans R Soc Trop Med Hyg, (1998). 92:381-5

Severe falciparum malaria in children: current understanding of pathophysiology and supportive treatment.Newton CR, Krishna S
Pharmacol Ther, (1998). 79:1-53

Neurological manifestations of falciparum malaria.Newton CR, Warrell DA
Ann Neurol, (1998). 43:695-702

A community randomized controlled trial of insecticide-treated bednets for the prevention of malaria and anaemia among primigravid women on the Kenyan coast.Shulman CE, Dorman EK, Talisuna AO, Lowe BS, Nevill C, Snow RW, Jilo H, Peshu N, Bulmer JN, Graham S, Marsh K
Trop Med Int Health, (1998). 3:197-204

Severe anaemia in children living in a malaria endemic area of Kenya.Newton CR, Warn PA, Winstanley PA, Peshu N, Snow RW, Pasvol G, Marsh K
Trop Med Int Health, (1997). 2:165-78

Receptor-specific adhesion and clinical disease in Plasmodium falciparum.Newbold C, Warn P, Black G, Berendt A, Craig A, Snow B, Msobo M, Peshu N, Marsh K
Am J Trop Med Hyg, (1997). 57:389-98

PfEMP1, polymorphism and pathogenesis.Newbold CI, Craig AG, Kyes S, Berendt AR, Snow RW, Peshu N, Marsh K
Ann Trop Med Parasitol, (1997). 91:551-7

The influence of alanine infusion on glucose production in 'malnourished' African children with falciparum malaria.Dekker E, Romijn JA, Moeniralam HS, Waruiru C, Ackermans MT, Timmer JG, Endert E, Peshu N, Marsh K, Sauerwein HP
QJM, (1997). 90:455-60